Registration is available here.
From the event summary:
“Pharmacovigilance is evolving rapidly and is becoming ever-important in the pharmaceutical industry. Health Authorities are continuously focusing on this area, and new legislation and policies from EU, as well as globally, are driving changes to processes and Technologies. Current PV trends include efficiency and performance of qualitative/empiric signal detection, joined activities in PASS and interdependencies in RMPs, complexities between company and EU- or local QPPV, the growing relevance of audits and training at PV inspections and the adequate methods of the continuous benefit/risk assessment of medicinal products. In addition, the pertinent role of quality assurance and the respective methods to be developed for every subject as well as the legal aspects based on law and adjudgement will be addressed in order to support the right decision making. Well-known speakers in pharmacovigilance from authorities, pharma industry, law office and service provider will discuss together openly supporting appropriate solutions if applicable”.